Answers are grounded in this paper and cite their sources.
Eosinophilic pustular folliculitis (EPF) is a rare inflammatory dermatosis that predominantly affects seborrheic areas. The condition's pathogenesis is linked to T helper 2-driven eosinophilic inflammation. We presented a man with EPF involving the face, palms and soles, successfully treated by apremilast, a phosphodiesterase-4 inhibitor. Apremilast's efficacy in this case adds to emerging evidence supporting its use in EPF, particularly when traditional treatments fail.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: